Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21202387 | 0.82 | ALDH1A1 (0.33) | — | |
| SCHEMBL20055052 | 0.78 | — | — | |
| SCHEMBL17995583 | 0.78 | LMNA (0.33) | LMNA | |
| SCHEMBL19346305 | 0.73 | HTR4 (0.30) | HTR4 | |
| SCHEMBL14210392 | 0.71 | HTR4 (0.32) | HTR4 | |
| SCHEMBL25125341 | 0.71 | HTR4 (0.32) | HTR4 | |
| SCHEMBL17995585 | 0.69 | HRH3 (0.43) | HTR4 | |
| SCHEMBL18270439 | 0.68 | HRH3 (0.36) | — | |
| SCHEMBL19256118 | 0.67 | — | — | |
| SCHEMBL22565081 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220153719-A1 | GPR119 AGONISTS | KALLYOPE, INC. | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220153719-A1 | GPR119 AGONISTS | GPR119, GLP1R, GCGR | LMNA 4659/4885HTR4 227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.